NCT02191865View on ClinicalTrials.gov

Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Hepatic Insufficiency
Interventions
DRUG

Nintedanib

Soft gelatine capsule

DRUG

Nintedanib

Soft gelatine capsule

DRUG

Nintedanib

Soft gelatine capsule

Trial Locations (1)

Unknown

1199.200.49001 Boehringer Ingelheim Investigational Site, Kiel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY